Occam Recruits Senior Pharma Executive to the Board of Geron
In March 2019, Occam Global placed Elizabeth G. O’Farrell on the Board of Geron Corporation, a publicly traded commercial-stage oncology biotech. Liz brings over 24 years of experience as a senior executive of Eli Lilly and Company, recently serving as Chief Procurement Officer. She is active on several boards, including Karius, Genmab, LENSAR, and PDL BioPharma.
Ms. O'Farrell holds a BS in accounting with honors and an MBA in Management Information Systems from Indiana University.
Read more about Occam's work with Geron in our case study.
Recent Placements
- Edith Hessel as CSO and Lindsay Edwards as CTO at Relation Therapeutics
- Dan Kemp as CEO of Shinobi Therapeutics
- Roy Larsen, PhD as CEO for RadioPharm Start-Up
- David Lynch as CBO at Strateos
- Craig Thompson as CEO at Cerevance
- Occam Recruits CSO for Public Gene Therapy Company, Adverum
- Occam Recruits Michael Miller to the Board of BioXcel
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.